Fibrogen FY 2022: revenue $140.7M, down 40%; diluted EPS −$3.14

Key figures from this report

These are the numbers Fibrogen reported for the year ended Dec 31, 2022, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$140.7M−40% from $235.3M in FY 202110-K income statement, on EDGAR
2. Net income−$293.7MAgainst −$290.0M in FY 202110-K income statement, on EDGAR
3. Diluted EPS−$3.14Against −$3.14 in FY 202110-K income statement, on EDGAR
4. Cash and cash equivalents$155.7M−9% from $171.2M in FY 2021Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
5. Cash from operations−$145.9MAgainst −$82.2M in FY 202110-K cash flow statement, on EDGAR

Every year in the financial tables